Management of Vulvar Abscess
Incision and drainage is the primary treatment for vulvar abscess, with adjunctive antibiotics required when systemic signs of infection are present, the abscess is large (>5 cm), there is significant surrounding cellulitis, or the patient has diabetes or immunocompromising conditions. 1, 2
Primary Treatment Approach
Surgical Management
- Incision and drainage is mandatory for all vulvar abscesses 1, 2
- For abscesses >5 cm, consider placement of a drain (such as Hemovac) to prevent reaccumulation 3
- Timing should be expeditious, particularly if systemic signs of infection or sepsis are present 4
When Antibiotics Are Required
Antibiotic therapy is strongly recommended in the following scenarios 1, 2:
- Severe or extensive disease involving multiple sites
- Rapid progression with associated cellulitis
- Signs of systemic illness (fever, elevated WBC, SIRS)
- Diabetes mellitus or other immunocompromising conditions
- Extremes of age
- Abscess in difficult-to-drain locations (face, hand, genitalia)
- Lack of response to incision and drainage alone
Antibiotic Selection
Empiric Coverage
Empiric antibiotic therapy must cover MRSA, as methicillin-resistant Staphylococcus aureus accounts for 43-64% of vulvar abscesses 5, 6.
Outpatient options:
- TMP-SMX (trimethoprim-sulfamethoxazole) - covers MRSA effectively
- Clindamycin (though resistance is increasing)
- Doxycycline or minocycline
- Levofloxacin + metronidazole (provides broader coverage including anaerobes)
- Gentamicin + clindamycin
Inpatient/severe infections:
- IV vancomycin
- Linezolid 600 mg PO/IV twice daily
- Daptomycin 4 mg/kg/dose IV
Duration
- 5-10 days of antibiotic therapy is recommended 1
- Individualize based on clinical response, but err toward the longer duration if diabetes or immunocompromise is present
Risk Stratification for Inpatient vs Outpatient Management
Inpatient Management Indicated When:
- Diabetes mellitus (most critical predictor - associated with longer hospitalization, need for reoperation, and progression to necrotizing fasciitis) 5
- Abscess size >5 cm 6
- Elevated WBC ≥12,000/mm³ 6
- Serum glucose >200 mg/dL 6
- Hypertension or other significant comorbidities 6
- Signs of systemic infection or sepsis 4
- Immunocompromised state 2
Outpatient Management Acceptable When:
- Small abscess (<5 cm)
- Fit, immunocompetent patient
- No systemic signs of sepsis
- No diabetes or other significant comorbidities 4
Critical Pitfalls to Avoid
Underestimating MRSA prevalence: Do not use beta-lactams alone or fluoroquinolones as monotherapy - they are inadequate for MRSA 1, 6
Missing diabetes: Check serum glucose, HbA1c, and urine ketones in all patients with vulvar abscess, as undiagnosed diabetes is common and dramatically worsens outcomes 4, 5
Delaying surgical drainage: Antibiotics alone are insufficient - source control through drainage is essential 1, 2
Failing to recognize necrotizing fasciitis: Diabetic patients with vulvar abscess have a 19% risk of progression to necrotizing fasciitis 5. Maintain high suspicion if pain seems disproportionate to physical findings, if there is rapid progression, or if systemic toxicity is present.
Inadequate drainage: For large abscesses, simple incision may be insufficient - consider drain placement to prevent reaccumulation 3
Special Considerations
Culture and Sensitivity
- Obtain abscess cultures, particularly in high-risk patients (diabetes, immunocompromise) or those with risk factors for multidrug-resistant organisms 4
- Adjust antibiotics based on culture results
Recurrence Prevention
The recurrence rate with appropriate surgical drainage and antibiotic therapy is very low (0-7.2%) 3, 7. Primary suture after incision, curettage, and antibiotic coverage has shown excellent results with median healing time of 7 days versus 18 days with conventional open treatment 7.
Laboratory Workup
For patients with systemic signs 4:
- Complete blood count
- Serum creatinine
- Inflammatory markers (CRP, procalcitonin, lactate)
- Blood glucose, HbA1c, urine ketones